Celebrating Tom - an evening of tributes and triumphs.

On 12th September, we celebrated the life and achievements of the wonderful Tom Isaacs - co-founder of The Cure Parkinson's Trust. Tom's incredible legacy remains at the absolute heart of the Trust.Read more

Alpha-synuclein oligomers: a new hope

A report part funded by The Cure Parkinson's Trust assesses the evidence for the toxicity and prion-like activity of oligomeric forms of alpha-synuclein and discusses the advances in our understanding of the role of alpha-synuclein in Parkinson’s and current approaches being taken to therapeutically target alpha-synuclein oligomers and their implications.Read more

The Association of Pesticide Use and Parkinson's

Researchers assessed the influence of occupational pesticide use on the prevalence of Parkinson's Disease in people with information available concerning occupational, residential, and household sources of pesticide exposure.Read more

Breaking News: Diabetes Drug Shows Potential as Disease-Modifying Therapy for Parkinson’s

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.Read more

Diabetes drug (Bydureon) Showed Potential as Disease-modifying Therapy for Parkinson's: More Research Needed

At a recent meeting, hosted by The Cure Parkinson's Trust, attendees discussed the impact of the recently published Bydureon trial, related research and the next steps needed for GLP-1 agonists in Parkinson's.Read more

CPT Approves Funding for Two Pre-clinical Studies of Anti-diabetic Drugs

MSDC-0160 and Exendin-4 have shown potential to slow the progression of Parkinson's in pre-clinical work funded by CPT. Moving these drugs to trial is now crucial.Read more

Reducing Inflammation in Parkinson's using a Clinically Approved Cancer Drug

Based on the wealth of evidence that inflammation plays a key role in diseases of the central nervous system, it is thought this line of treatment using a clinically approved cancer drug has significant potential to slow or stop disease progression in Parkinson's.Read more

FDA Approval of Nilotinib in Collaboration Trial

The Cure Parkinson's Trust has collaborated with The Michael J Fox Foundation (MJFF) and the Van Andel Research Institute (VARI) of Grand Rapids, Michigan on the clinical development of nilotinib toward the launch of this clinical trial.Read more

Tribute to Tom

Clare Balding and CPT's own Helen Matthews pay a wonderful tribute to Tom Isaacs on BBC Radio 4, Last Word.Read more

Dogs to be Taught to Sniff Out Parkinson's

Dogs could soon be used to sniff out Parkinson’s disease years before symptoms start to show.Read more

Clinical Data Sharing by People with Parkinson's - paper published

Clinical data sharing and ownership are key issues in modern digital data acquisition. Data sharing is subject to influence by a range of stakeholders. Of these, patient attitudes are pivotal.Read more

Abnormal Protein in Parkinson's Triggers an Immune Response

Researchers have found the first direct evidence that autoimmunity -- in which the immune system attacks the body's own tissues -- plays a role in Parkinson's Disease.Read more

The Cure Parkinson's Trust & Parkinson’s Community Mourn the Loss of Their Champion

“So how has the task of finding better treatments for Parkinson’s made me more passionate, more determined and more fulfilled in my life than I ever thought possible? The answer to this question is simple. It’s the people." - Tom IsaacsRead more

Tom Isaacs

We are devastated to announce that Tom Isaacs, President and Co-founder of The Cure Parkinson’s Trust (CPT) died on Wednesday morning (31st May). Tom’s passing was unexpected and swift.Read more

The Mike Tindall Celebrity Golf Classic supports The Cure Parkinson's Trust

Celebrities from the world of rugby, golf and entertainment joined rugby legend Mike Tindall at the 5th ISPS HANDA Mike Tindall Celebrity Golf Classic, held at The Belfry to help raise funds in support of The Cure Parkinson’s Trust...Read more

Licenced Drug Simvastatin shows Promising Neurological Results

Scientists have worked for years to find a potential treatment that could help people, and now, finally, one has been found that might ~ Dr Susan Kohlhaas, MS SocietyRead more

Cambridge Cognition Ceilidh

Huge thanks to the Cambridge Cognition who have chosen The Cure Parkinson's Trust as their 2017 charity of the year holding a lively Ceilidh with music by the Cambridge University Band to raise money for our research...Read more

Teacher Stern Solicits Substantial Funds for CPT!

The Cure Parkinson's Trust (CPT) enjoyed a wonderful evening of hospitality and networking at the Teacher Stern Solicitors Property evening last Thursday.Read more

The Daily Telegraph: Mike Tindall Supports The Cure Parkinson's Trust

In a recent article in The Telegraph ex-England rugby player Mike Tindall talks about the impact of his father's diagnosis of Parkinson's and why The Cure Parkinson's Trust is important to him...Read more

The Gulls Eggs Luncheon 2017

For the second year running, The Cure Parkinson's Trust was the beneficiary of the annual City-based Gulls Eggs luncheon. Guests were treated to a delightful lunch of the seasonal gulls' eggs whilst generously supporting the work of the Trust.Read more

Our 2017 Annual Review

Find out more about our fantastic achievements over the year...Read more